in Health care
Health Canada approves Chiesi Ferriprox MR Deferiprone ER tablets for patients with transfusional iron overload
Delhi: Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver innovative therapies and solutions for people affected by rare diseases, announced that Health Canada has approved Ferriprox MR deferiprone extended-release tablets 1 000 mg for the treatment of patients with transfusional iron overload due to thalassemia syndromes when current chelation […] More
